Cost-effectiveness of Ribociclib in HER2- negative breast cancer: A synthesis of current evidence

• मुख्य लेखकों: Wedad H. Alotaibi (लेखक), Majd M. Alhamdan (लेखक), Bander Balkhi (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2022-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: The main aim of this study was to investigate the cost-effectiveness of Ribociclib in the treatment of patients with breast cancer by assessing the published evidence. Method: A systematic review of the published literature was conducted to identify the economic evaluations/cost-effectiv...